Literature DB >> 31983247

ONECUT2 is a novel target for treatment of castration-resistant prostate cancer.

Tejashree Joglekar1,2, Jianqing Lin2,3, Maho Shibata1,2.   

Abstract

Entities:  

Keywords:  AR-independent prostate cancer; ONECUT2; castration-resistant prostate cancer; neuroendocrine prostate cancer; prostate cancer

Mesh：

Substances：

Year:  2020        PMID： 31983247      PMCID： PMC7523780          DOI： 10.1080/14728222.2020.1723080

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN： 1472-8222            Impact factor:   6.902


× No keyword cloud information.
  10 in total

1.  ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis.

Authors:  Mirja Rotinen; Sungyong You; Julie Yang; Simon G Coetzee; Mariana Reis-Sobreiro; Wen-Chin Huang; Fangjin Huang; Xinlei Pan; Alberto Yáñez; Dennis J Hazelett; Chia-Yi Chu; Kenneth Steadman; Colm M Morrissey; Peter S Nelson; Eva Corey; Leland W K Chung; Stephen J Freedland; Dolores Di Vizio; Isla P Garraway; Ramachandran Murali; Beatrice S Knudsen; Michael R Freeman
Journal:  Nat Med       Date:  2018-11-26       Impact factor: 53.440

2.  From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer.

Authors:  Anna V Lapuk; Chunxiao Wu; Alexander W Wyatt; Andrew McPherson; Brian J McConeghy; Sonal Brahmbhatt; Fan Mo; Amina Zoubeidi; Shawn Anderson; Robert H Bell; Anne Haegert; Robert Shukin; Yuzhuo Wang; Ladan Fazli; Antonio Hurtado-Coll; Edward C Jones; Faraz Hach; Fereydoun Hormozdiari; Iman Hajirasouliha; Paul C Boutros; Robert G Bristow; Yongjun Zhao; Marco A Marra; Andrea Fanjul; Christopher A Maher; Arul M Chinnaiyan; Mark A Rubin; Himisha Beltran; S Cenk Sahinalp; Martin E Gleave; Stanislav V Volik; Colin C Collins
Journal:  J Pathol       Date:  2012-07       Impact factor: 7.996

3.  Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer.

Authors:  Min Zou; Roxanne Toivanen; Antonina Mitrofanova; Nicolas Floch; Sheida Hayati; Yanping Sun; Clémentine Le Magnen; Daniel Chester; Elahe A Mostaghel; Andrea Califano; Mark A Rubin; Michael M Shen; Cory Abate-Shen
Journal:  Cancer Discov       Date:  2017-04-14       Impact factor: 39.397

4.  The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.

Authors:  Shusuke Akamatsu; Alexander W Wyatt; Dong Lin; Summer Lysakowski; Fan Zhang; Soojin Kim; Charan Tse; Kendric Wang; Fan Mo; Anne Haegert; Sonal Brahmbhatt; Robert Bell; Hans Adomat; Yoshihisa Kawai; Hui Xue; Xin Dong; Ladan Fazli; Harrison Tsai; Tamara L Lotan; Myriam Kossai; Juan Miguel Mosquera; Mark A Rubin; Himisha Beltran; Amina Zoubeidi; Yuzhuo Wang; Martin E Gleave; Colin C Collins
Journal:  Cell Rep       Date:  2015-07-30       Impact factor: 9.423

5.  Platinum-based chemotherapy for variant castrate-resistant prostate cancer.

Authors:  Ana M Aparicio; Andrea L Harzstark; Paul G Corn; Sijin Wen; John C Araujo; Shi-Ming Tu; Lance C Pagliaro; Jeri Kim; Randall E Millikan; Charles Ryan; Nizar M Tannir; Amado J Zurita; Paul Mathew; Wadih Arap; Patricia Troncoso; Peter F Thall; Christopher J Logothetis
Journal:  Clin Cancer Res       Date:  2013-05-06       Impact factor: 12.531

6.  Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling.

Authors:  Eric G Bluemn; Ilsa M Coleman; Jared M Lucas; Roger T Coleman; Susana Hernandez-Lopez; Robin Tharakan; Daniella Bianchi-Frias; Ruth F Dumpit; Arja Kaipainen; Alexandra N Corella; Yu Chi Yang; Michael D Nyquist; Elahe Mostaghel; Andrew C Hsieh; Xiaotun Zhang; Eva Corey; Lisha G Brown; Holly M Nguyen; Kenneth Pienta; Michael Ittmann; Michael Schweizer; Lawrence D True; David Wise; Paul S Rennie; Robert L Vessella; Colm Morrissey; Peter S Nelson
Journal:  Cancer Cell       Date:  2017-10-09       Impact factor: 31.743

7.  Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.

Authors:  Himisha Beltran; Davide Prandi; Juan Miguel Mosquera; Matteo Benelli; Loredana Puca; Joanna Cyrta; Clarisse Marotz; Eugenia Giannopoulou; Balabhadrapatruni V S K Chakravarthi; Sooryanarayana Varambally; Scott A Tomlins; David M Nanus; Scott T Tagawa; Eliezer M Van Allen; Olivier Elemento; Andrea Sboner; Levi A Garraway; Mark A Rubin; Francesca Demichelis
Journal:  Nat Med       Date:  2016-02-08       Impact factor: 53.440

8.  Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses.

Authors:  Qiuhui Li; Qu Deng; Hsueh-Ping Chao; Xin Liu; Yue Lu; Kevin Lin; Bigang Liu; Gregory W Tang; Dingxiao Zhang; Amanda Tracz; Collene Jeter; Kiera Rycaj; Tammy Calhoun-Davis; Jiaoti Huang; Mark A Rubin; Himisha Beltran; Jianjun Shen; Gurkamal Chatta; Igor Puzanov; James L Mohler; Jianmin Wang; Ruizhe Zhao; Jason Kirk; Xin Chen; Dean G Tang
Journal:  Nat Commun       Date:  2018-09-06       Impact factor: 14.919

9.  ONECUT2 is a driver of neuroendocrine prostate cancer.

Authors:  Haiyang Guo; Xinpei Ci; Musaddeque Ahmed; Junjie Tony Hua; Fraser Soares; Dong Lin; Loredana Puca; Aram Vosoughi; Hui Xue; Estelle Li; Peiran Su; Sujun Chen; Tran Nguyen; Yi Liang; Yuzhe Zhang; Xin Xu; Jing Xu; Anjali V Sheahan; Wail Ba-Alawi; Si Zhang; Osman Mahamud; Ravi N Vellanki; Martin Gleave; Robert G Bristow; Benjamin Haibe-Kains; John T Poirier; Charles M Rudin; Ming-Sound Tsao; Bradly G Wouters; Ladan Fazli; Felix Y Feng; Leigh Ellis; Theo van der Kwast; Alejandro Berlin; Marianne Koritzinsky; Paul C Boutros; Amina Zoubeidi; Himisha Beltran; Yuzhuo Wang; Housheng Hansen He
Journal:  Nat Commun       Date:  2019-01-17       Impact factor: 14.919

10.  ONECUT2 overexpression promotes RAS-driven lung adenocarcinoma progression.

Authors:  Qingyang Ma; Kai Wu; Hui Li; Huichun Li; Yufei Zhu; Guohong Hu; Landian Hu; Xiangyin Kong
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379
  10 in total
  1 in total

1.  Identification of EMT-Related Gene Signatures to Predict the Prognosis of Patients With Endometrial Cancer.

Authors:  Luya Cai; Chuan Hu; Shanshan Yu; Lixiao Liu; Jinduo Zhao; Ye Zhao; Fan Lin; Xuedan Du; Qiongjie Yu; Qinqin Xiao
Journal:  Front Genet       Date:  2020-12-02       Impact factor: 4.599
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.